METHOTREXATE AS A SINGLE AGENT AND IN COMBINATION CHEMOTHERAPY FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA OF UNFAVORABLE HISTOLOGY

被引：0
作者：
CANELLOS, GP
SKARIN, AT
ROSENTHAL, DS
MOLONEY, WC
FREI, E
机构：
[1] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
[2] PETER BENT BRIGHAM HOSP,DIV HEMATOL,BOSTON,MA 02115
来源：
CANCER TREATMENT REPORTS | 1981年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：125 / 129
页数：5
相关论文
共 25 条
  • [1] AMERICAN BURKITTS-LYMPHOMA - CLINICOPATHOLOGIC STUDY OF 30 CASES .1. CLINICAL FACTORS RELATING TO PROLONGED SURVIVAL
    ARSENEAU, JC
    CANELLOS, GP
    BANKS, PM
    BERARD, CW
    GRALNICK, HR
    DEVITA, VT
    [J]. AMERICAN JOURNAL OF MEDICINE, 1975, 58 (03) : 314 - 321
  • [2] BERD D, 1975, CANCER, V35, P1050, DOI 10.1002/1097-0142(197504)35:4<1050::AID-CNCR2820350406>3.0.CO
  • [3] 2-F
  • [4] CANELLOS GP, 1978, CANCER, V42, P932, DOI 10.1002/1097-0142(197808)42:2+<932::AID-CNCR2820420716>3.0.CO
  • [5] 2-2
  • [6] PROGNOSTIC FACTORS FOR ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA FOLLOWING TREATMENT WITH COMBINATION CHEMOTHERAPY
    FISHER, RI
    DEVITA, VT
    JOHNSON, BL
    SIMON, R
    YOUNG, RC
    [J]. AMERICAN JOURNAL OF MEDICINE, 1977, 63 (02) : 177 - 182
  • [7] FREI E, 1975, NEW ENGL J MED, V292, P846
  • [8] HENRY JM, 1974, CANCER, V34, P1293, DOI 10.1002/1097-0142(197410)34:4<1293::AID-CNCR2820340441>3.0.CO
  • [9] 2-P
  • [10] HERBST KD, 1976, CANCER, V38, P1476, DOI 10.1002/1097-0142(197610)38:4<1476::AID-CNCR2820380405>3.0.CO
123